English
简体中文
Total: £ 56.28
Published Date: 2026-04-29 | Pages: 130 | Tables: 133 | Pharma & Healthcare
The global Medical Nuclide Products market was valued at US$ 11150 million in 2025 and is anticipated to reach US$ 20510 million by 2032, at a CAGR of 9.2% from 2026 to 2032.
Medical nuclide products refer to medical preparations or devices containing radioactive isotopes, which achieve diagnostic or therapeutic functions through the radiation released by their decay. Such products must strictly comply with radioactive safety standards and are widely used in the field of nuclear medicine. For example, imaging agents used in diagnosis assist in disease detection through gamma-ray imaging, and iodine-131 and lutetium-177 used in treatment destroy diseased tissues through targeted radiation. Their production, quality control and clinical use are subject to the dual constraints of national nuclear safety regulations and the drug regulatory system to ensure patient safety and the effectiveness of diagnosis and treatment.
The global medical nuclide products market is being driven by the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions, which require precise diagnostic imaging and targeted radiopharmaceutical therapies. Technological advancements in nuclear imaging modalities like PET and SPECT, combined with the increasing adoption of theranostic approaches, have significantly expanded clinical applications for medical nuclides. In addition, favorable government initiatives to promote nuclear medicine infrastructure, and increasing investment in radioisotope production facilities, particularly in developing regions, are further accelerating market growth.
Despite its potential, the medical nuclide products market faces several challenges. The short half-life of many radioisotopes requires localized and timely production, which puts pressure on logistics and supply chain networks, especially in geographically dispersed regions. Regulatory complexities surrounding the handling, transport, and storage of radioactive materials also increase operational burden. Moreover, a global shortage of key isotopes like Mo-99, and limited access to cyclotrons and nuclear reactors in many countries, hampers consistent supply. High costs and the scarcity of trained nuclear medicine professionals further constrain market expansion in certain areas.
This report delivers a comprehensive overview of the global Medical Nuclide Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Nuclide Products. The Medical Nuclide Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Nuclide Products market comprehensively. Regional market sizes by Type, by Application, by Product, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Nuclide Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Cardinal Health
GE Healthcare
Lantheus Medical Imaging
Bayer
Eli Lilly
Bracco Imaging
Curium Pharma
Jubilant Pharmova
Aurobindo Pharma
Novartis
Siemens
NTP Radioisotopes
ANSTO
Polatom
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Saide Biotechnology
Segment by Type
Technetium-99m
Fluorine-18
Gallium-68
Iodine-123
Indium-111
Copper-64
Xenon-133
Iodine-131
Yttrium-90
Lutetium-177
Strontium-89
Samarium-153
Radium-223
Iodine-125
Other
Segment by Product
Therapeutic Nuclear Medicine
Diagnostic Nuclear Medicine
Segment by Application
Cancer
Cardiovascular Disease
Bone and Joint Disease
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Product, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Medical Nuclide Products companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Nuclide Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Technetium-99m
1.2.3 Fluorine-18
1.2.4 Gallium-68
1.2.5 Iodine-123
1.2.6 Indium-111
1.2.7 Copper-64
1.2.8 Xenon-133
1.2.9 Iodine-131
1.2.10 Yttrium-90
1.3 Market by Product
1.3.1 Global Medical Nuclide Products Market Size Growth Rate by Product: 2021 vs 2025 vs 2032
1.3.2 Therapeutic Nuclear Medicine
1.3.3 Diagnostic Nuclear Medicine
1.4 Market by Application
1.4.1 Global Medical Nuclide Products Market Growth by Application: 2021 vs 2025 vs 2032
1.4.2 Cancer
1.4.3 Cardiovascular Disease
1.4.4 Bone and Joint Disease
1.4.5 Other
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Medical Nuclide Products Market Perspective (2021–2032)
2.2 Global Medical Nuclide Products Growth Trends by Region
2.2.1 Global Medical Nuclide Products Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Medical Nuclide Products Historic Market Size by Region (2021–2026)
2.2.3 Medical Nuclide Products Forecasted Market Size by Region (2027–2032)
2.3 Medical Nuclide Products Market Dynamics
2.3.1 Medical Nuclide Products Industry Trends
2.3.2 Medical Nuclide Products Market Drivers
2.3.3 Medical Nuclide Products Market Challenges
2.3.4 Medical Nuclide Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Nuclide Products Players by Revenue
3.1.1 Global Top Medical Nuclide Products Players by Revenue (2021–2026)
3.1.2 Global Medical Nuclide Products Revenue Market Share by Players (2021–2026)
3.2 Global Top Medical Nuclide Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Medical Nuclide Products Revenue
3.4 Global Medical Nuclide Products Market Concentration Ratio
3.4.1 Global Medical Nuclide Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Nuclide Products Revenue in 2025
3.5 Global Key Players of Medical Nuclide Products Head Offices and Areas Served
3.6 Global Key Players of Medical Nuclide Products, Products and Applications
3.7 Global Key Players of Medical Nuclide Products, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Medical Nuclide Products Breakdown Data by Type
4.1 Global Medical Nuclide Products Historic Market Size by Type (2021–2026)
4.2 Global Medical Nuclide Products Forecasted Market Size by Type (2027–2032)
5 Medical Nuclide Products Breakdown Data by Application
5.1 Global Medical Nuclide Products Historic Market Size by Application (2021–2026)
5.2 Global Medical Nuclide Products Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Medical Nuclide Products Market Size (2021–2032)
6.2 North America Medical Nuclide Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Medical Nuclide Products Market Size by Country (2021–2026)
6.4 North America Medical Nuclide Products Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical Nuclide Products Market Size (2021–2032)
7.2 Europe Medical Nuclide Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Medical Nuclide Products Market Size by Country (2021–2026)
7.4 Europe Medical Nuclide Products Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Medical Nuclide Products Market Size (2021–2032)
8.2 Asia-Pacific Medical Nuclide Products Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Medical Nuclide Products Market Size by Region (2021–2026)
8.4 Asia-Pacific Medical Nuclide Products Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Medical Nuclide Products Market Size (2021–2032)
9.2 Latin America Medical Nuclide Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Medical Nuclide Products Market Size by Country (2021–2026)
9.4 Latin America Medical Nuclide Products Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Nuclide Products Market Size (2021–2032)
10.2 Middle East & Africa Medical Nuclide Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Medical Nuclide Products Market Size by Country (2021–2026)
10.4 Middle East & Africa Medical Nuclide Products Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Medical Nuclide Products Introduction
11.1.4 Cardinal Health Revenue in Medical Nuclide Products Business (2021–2026)
11.1.5 Cardinal Health Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Medical Nuclide Products Introduction
11.2.4 GE Healthcare Revenue in Medical Nuclide Products Business (2021–2026)
11.2.5 GE Healthcare Recent Development
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Company Details
11.3.2 Lantheus Medical Imaging Business Overview
11.3.3 Lantheus Medical Imaging Medical Nuclide Products Introduction
11.3.4 Lantheus Medical Imaging Revenue in Medical Nuclide Products Business (2021–2026)
11.3.5 Lantheus Medical Imaging Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Medical Nuclide Products Introduction
11.4.4 Bayer Revenue in Medical Nuclide Products Business (2021–2026)
11.4.5 Bayer Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Medical Nuclide Products Introduction
11.5.4 Eli Lilly Revenue in Medical Nuclide Products Business (2021–2026)
11.5.5 Eli Lilly Recent Development
11.6 Bracco Imaging
11.6.1 Bracco Imaging Company Details
11.6.2 Bracco Imaging Business Overview
11.6.3 Bracco Imaging Medical Nuclide Products Introduction
11.6.4 Bracco Imaging Revenue in Medical Nuclide Products Business (2021–2026)
11.6.5 Bracco Imaging Recent Development
11.7 Curium Pharma
11.7.1 Curium Pharma Company Details
11.7.2 Curium Pharma Business Overview
11.7.3 Curium Pharma Medical Nuclide Products Introduction
11.7.4 Curium Pharma Revenue in Medical Nuclide Products Business (2021–2026)
11.7.5 Curium Pharma Recent Development
11.8 Jubilant Pharmova
11.8.1 Jubilant Pharmova Company Details
11.8.2 Jubilant Pharmova Business Overview
11.8.3 Jubilant Pharmova Medical Nuclide Products Introduction
11.8.4 Jubilant Pharmova Revenue in Medical Nuclide Products Business (2021–2026)
11.8.5 Jubilant Pharmova Recent Development
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Company Details
11.9.2 Aurobindo Pharma Business Overview
11.9.3 Aurobindo Pharma Medical Nuclide Products Introduction
11.9.4 Aurobindo Pharma Revenue in Medical Nuclide Products Business (2021–2026)
11.9.5 Aurobindo Pharma Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Medical Nuclide Products Introduction
11.10.4 Novartis Revenue in Medical Nuclide Products Business (2021–2026)
11.10.5 Novartis Recent Development
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Medical Nuclide Products Introduction
11.11.4 Siemens Revenue in Medical Nuclide Products Business (2021–2026)
11.11.5 Siemens Recent Development
11.12 NTP Radioisotopes
11.12.1 NTP Radioisotopes Company Details
11.12.2 NTP Radioisotopes Business Overview
11.12.3 NTP Radioisotopes Medical Nuclide Products Introduction
11.12.4 NTP Radioisotopes Revenue in Medical Nuclide Products Business (2021–2026)
11.12.5 NTP Radioisotopes Recent Development
11.13 ANSTO
11.13.1 ANSTO Company Details
11.13.2 ANSTO Business Overview
11.13.3 ANSTO Medical Nuclide Products Introduction
11.13.4 ANSTO Revenue in Medical Nuclide Products Business (2021–2026)
11.13.5 ANSTO Recent Development
11.14 Polatom
11.14.1 Polatom Company Details
11.14.2 Polatom Business Overview
11.14.3 Polatom Medical Nuclide Products Introduction
11.14.4 Polatom Revenue in Medical Nuclide Products Business (2021–2026)
11.14.5 Polatom Recent Development
11.15 China Isotope & Radiation
11.15.1 China Isotope & Radiation Company Details
11.15.2 China Isotope & Radiation Business Overview
11.15.3 China Isotope & Radiation Medical Nuclide Products Introduction
11.15.4 China Isotope & Radiation Revenue in Medical Nuclide Products Business (2021–2026)
11.15.5 China Isotope & Radiation Recent Development
11.16 Yantai Dongcheng Pharmaceutical
11.16.1 Yantai Dongcheng Pharmaceutical Company Details
11.16.2 Yantai Dongcheng Pharmaceutical Business Overview
11.16.3 Yantai Dongcheng Pharmaceutical Medical Nuclide Products Introduction
11.16.4 Yantai Dongcheng Pharmaceutical Revenue in Medical Nuclide Products Business (2021–2026)
11.16.5 Yantai Dongcheng Pharmaceutical Recent Development
11.17 Saide Biotechnology
11.17.1 Saide Biotechnology Company Details
11.17.2 Saide Biotechnology Business Overview
11.17.3 Saide Biotechnology Medical Nuclide Products Introduction
11.17.4 Saide Biotechnology Revenue in Medical Nuclide Products Business (2021–2026)
11.17.5 Saide Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Medical Nuclide Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Technetium-99m
Table 3. Key Players of Fluorine-18
Table 4. Key Players of Gallium-68
Table 5. Key Players of Iodine-123
Table 6. Key Players of Indium-111
Table 7. Key Players of Copper-64
Table 8. Key Players of Xenon-133
Table 9. Global Medical Nuclide Products Market Size Growth Rate by Product (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Therapeutic Nuclear Medicine
Table 11. Key Players of Diagnostic Nuclear Medicine
Table 12. Global Medical Nuclide Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Medical Nuclide Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Medical Nuclide Products Market Size by Region (US$ Million), 2021–2026
Table 15. Global Medical Nuclide Products Market Share by Region (2021–2026)
Table 16. Global Medical Nuclide Products Forecasted Market Size by Region (US$ Million), 2027–2032
Table 17. Global Medical Nuclide Products Market Share by Region (2027–2032)
Table 18. Medical Nuclide Products Market Trends
Table 19. Medical Nuclide Products Market Drivers
Table 20. Medical Nuclide Products Market Challenges
Table 21. Medical Nuclide Products Market Restraints
Table 22. Global Medical Nuclide Products Revenue by Players (US$ Million), 2021–2026
Table 23. Global Medical Nuclide Products Market Share by Players (2021–2026)
Table 24. Global Top Medical Nuclide Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on Medical Nuclide Products Revenue, 2025
Table 25. Ranking of Global Top Medical Nuclide Products Companies by Revenue (US$ Million) in 2025
Table 26. Global 5 Largest Players Market Share by Medical Nuclide Products Revenue (CR5 and HHI), 2021–2026
Table 27. Global Key Players of Medical Nuclide Products, Headquarters and Area Served
Table 28. Global Key Players of Medical Nuclide Products, Products and Applications
Table 29. Global Key Players of Medical Nuclide Products, Date of General Availability (GA)
Table 30. Mergers and Acquisitions, Expansion Plans
Table 31. Global Medical Nuclide Products Market Size by Type (US$ Million), 2021–2026
Table 32. Global Medical Nuclide Products Revenue Market Share by Type (2021–2026)
Table 33. Global Medical Nuclide Products Forecasted Market Size by Type (US$ Million), 2027–2032
Table 34. Global Medical Nuclide Products Revenue Market Share by Type (2027–2032)
Table 35. Global Medical Nuclide Products Market Size by Application (US$ Million), 2021–2026
Table 36. Global Medical Nuclide Products Revenue Market Share by Application (2021–2026)
Table 37. Global Medical Nuclide Products Forecasted Market Size by Application (US$ Million), 2027–2032
Table 38. Global Medical Nuclide Products Revenue Market Share by Application (2027–2032)
Table 39. North America Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 40. North America Medical Nuclide Products Market Size by Country (US$ Million), 2021–2026
Table 41. North America Medical Nuclide Products Market Size by Country (US$ Million), 2027–2032
Table 42. Europe Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Europe Medical Nuclide Products Market Size by Country (US$ Million), 2021–2026
Table 44. Europe Medical Nuclide Products Market Size by Country (US$ Million), 2027–2032
Table 45. Asia-Pacific Medical Nuclide Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 46. Asia-Pacific Medical Nuclide Products Market Size by Region (US$ Million), 2021–2026
Table 47. Asia-Pacific Medical Nuclide Products Market Size by Region (US$ Million), 2027–2032
Table 48. Latin America Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Latin America Medical Nuclide Products Market Size by Country (US$ Million), 2021–2026
Table 50. Latin America Medical Nuclide Products Market Size by Country (US$ Million), 2027–2032
Table 51. Middle East & Africa Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Middle East & Africa Medical Nuclide Products Market Size by Country (US$ Million), 2021–2026
Table 53. Middle East & Africa Medical Nuclide Products Market Size by Country (US$ Million), 2027–2032
Table 54. Cardinal Health Company Details
Table 55. Cardinal Health Business Overview
Table 56. Cardinal Health Medical Nuclide Products Product
Table 57. Cardinal Health Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 58. Cardinal Health Recent Development
Table 59. GE Healthcare Company Details
Table 60. GE Healthcare Business Overview
Table 61. GE Healthcare Medical Nuclide Products Product
Table 62. GE Healthcare Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 63. GE Healthcare Recent Development
Table 64. Lantheus Medical Imaging Company Details
Table 65. Lantheus Medical Imaging Business Overview
Table 66. Lantheus Medical Imaging Medical Nuclide Products Product
Table 67. Lantheus Medical Imaging Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 68. Lantheus Medical Imaging Recent Development
Table 69. Bayer Company Details
Table 70. Bayer Business Overview
Table 71. Bayer Medical Nuclide Products Product
Table 72. Bayer Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 73. Bayer Recent Development
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Medical Nuclide Products Product
Table 77. Eli Lilly Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 78. Eli Lilly Recent Development
Table 79. Bracco Imaging Company Details
Table 80. Bracco Imaging Business Overview
Table 81. Bracco Imaging Medical Nuclide Products Product
Table 82. Bracco Imaging Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 83. Bracco Imaging Recent Development
Table 84. Curium Pharma Company Details
Table 85. Curium Pharma Business Overview
Table 86. Curium Pharma Medical Nuclide Products Product
Table 87. Curium Pharma Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 88. Curium Pharma Recent Development
Table 89. Jubilant Pharmova Company Details
Table 90. Jubilant Pharmova Business Overview
Table 91. Jubilant Pharmova Medical Nuclide Products Product
Table 92. Jubilant Pharmova Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 93. Jubilant Pharmova Recent Development
Table 94. Aurobindo Pharma Company Details
Table 95. Aurobindo Pharma Business Overview
Table 96. Aurobindo Pharma Medical Nuclide Products Product
Table 97. Aurobindo Pharma Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 98. Aurobindo Pharma Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Medical Nuclide Products Product
Table 102. Novartis Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 103. Novartis Recent Development
Table 104. Siemens Company Details
Table 105. Siemens Business Overview
Table 106. Siemens Medical Nuclide Products Product
Table 107. Siemens Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 108. Siemens Recent Development
Table 109. NTP Radioisotopes Company Details
Table 110. NTP Radioisotopes Business Overview
Table 111. NTP Radioisotopes Medical Nuclide Products Product
Table 112. NTP Radioisotopes Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 113. NTP Radioisotopes Recent Development
Table 114. ANSTO Company Details
Table 115. ANSTO Business Overview
Table 116. ANSTO Medical Nuclide Products Product
Table 117. ANSTO Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 118. ANSTO Recent Development
Table 119. Polatom Company Details
Table 120. Polatom Business Overview
Table 121. Polatom Medical Nuclide Products Product
Table 122. Polatom Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 123. Polatom Recent Development
Table 124. China Isotope & Radiation Company Details
Table 125. China Isotope & Radiation Business Overview
Table 126. China Isotope & Radiation Medical Nuclide Products Product
Table 127. China Isotope & Radiation Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 128. China Isotope & Radiation Recent Development
Table 129. Yantai Dongcheng Pharmaceutical Company Details
Table 130. Yantai Dongcheng Pharmaceutical Business Overview
Table 131. Yantai Dongcheng Pharmaceutical Medical Nuclide Products Product
Table 132. Yantai Dongcheng Pharmaceutical Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 133. Yantai Dongcheng Pharmaceutical Recent Development
Table 134. Saide Biotechnology Company Details
Table 135. Saide Biotechnology Business Overview
Table 136. Saide Biotechnology Medical Nuclide Products Product
Table 137. Saide Biotechnology Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026
Table 138. Saide Biotechnology Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. Authors List of This Report
List of Figures
Figure 1. Medical Nuclide Products Picture
Figure 2. Global Medical Nuclide Products Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Medical Nuclide Products Market Share by Type: 2025 vs 2032
Figure 4. Technetium-99m Features
Figure 5. Fluorine-18 Features
Figure 6. Gallium-68 Features
Figure 7. Iodine-123 Features
Figure 8. Indium-111 Features
Figure 9. Copper-64 Features
Figure 10. Xenon-133 Features
Figure 11. Iodine-131 Features
Figure 12. Yttrium-90 Features
Figure 13. Global Medical Nuclide Products Market Size Comparison by Product (US$ Million), 2021–2032
Figure 14. Therapeutic Nuclear Medicine Features
Figure 15. Diagnostic Nuclear Medicine Features
Figure 16. Global Medical Nuclide Products Market Size by Application (US$ Million), 2021–2032
Figure 17. Global Medical Nuclide Products Market Share by Application: 2025 vs 2032
Figure 18. Cancer Case Studies
Figure 19. Cardiovascular Disease Case Studies
Figure 20. Bone and Joint Disease Case Studies
Figure 21. Other Case Studies
Figure 22. Medical Nuclide Products Report Years Considered
Figure 23. Global Medical Nuclide Products Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 24. Global Medical Nuclide Products Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Medical Nuclide Products Market Share by Region: 2025 vs 2032
Figure 26. Global Medical Nuclide Products Market Share by Players in 2025
Figure 27. Global Medical Nuclide Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Medical Nuclide Products Revenue in 2025
Figure 29. North America Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. North America Medical Nuclide Products Market Share by Country (2021–2032)
Figure 31. United States Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Canada Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe Medical Nuclide Products Market Share by Country (2021–2032)
Figure 35. Germany Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. France Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. U.K. Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Italy Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Russia Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Ireland Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific Medical Nuclide Products Market Share by Region (2021–2032)
Figure 43. China Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Japan Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. South Korea Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Southeast Asia Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. India Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Australia & New Zealand Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America Medical Nuclide Products Market Share by Country (2021–2032)
Figure 51. Mexico Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Brazil Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa Medical Nuclide Products Market Share by Country (2021–2032)
Figure 55. Israel Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Saudi Arabia Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. UAE Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Cardinal Health Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 59. GE Healthcare Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 60. Lantheus Medical Imaging Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 61. Bayer Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 62. Eli Lilly Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 63. Bracco Imaging Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 64. Curium Pharma Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 65. Jubilant Pharmova Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 66. Aurobindo Pharma Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 67. Novartis Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 68. Siemens Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 69. NTP Radioisotopes Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 70. ANSTO Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 71. Polatom Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 72. China Isotope & Radiation Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 73. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 74. Saide Biotechnology Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
